Terns Pharmaceuticals, Inc. (TERN)
40.40
-0.19
(-0.47%)
USD |
NASDAQ |
Dec 31, 16:00
40.69
+0.29
(+0.72%)
After-Hours: 20:00
Terns Pharmaceuticals Cash from Investing (Quarterly): 24.50M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Altimmune, Inc. | -149.32M |
| Ligand Pharmaceuticals, Inc. | -353.44M |
| ADMA Biologics, Inc. | -14.37M |
| Viking Therapeutics, Inc. | 160.02M |
| Cidara Therapeutics, Inc. | -176.47M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -19.77M |
| Free Cash Flow | -77.99M |
| Free Cash Flow Per Share (Quarterly) | -0.2156 |
| Free Cash Flow to Equity (Quarterly) | -19.67M |
| Free Cash Flow to Firm (Quarterly) | -19.77M |
| Free Cash Flow Yield | -2.11% |